tiprankstipranks
Ondine Biomedical, Inc. (GB:OBI)
:OBI
UK Market

Ondine Biomedical, Inc. (OBI) Income Statement

Compare
7 Followers

Ondine Biomedical, Inc. Income Statement

Last quarter (Q4 2023), Ondine Biomedical, Inc.'s total revenue was C$―, a decrease of ― from previous quarter. In Q4, Ondine Biomedical, Inc.'s net income was C$―. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 1.20MC$ 638.00KC$ 2.57MC$ 1.79MC$ 464.00K
Gross Profit
C$ 703.00KC$ 287.00KC$ 1.25MC$ 649.00KC$ 136.00K
Operating Expenses
C$ 15.51MC$ 19.05MC$ 18.77MC$ 16.52MC$ 14.16M
Depreciation and Amortization
C$ 587.00KC$ 493.00KC$ 514.00KC$ 1.22MC$ 1.22M
EBITDA
C$ -13.79MC$ -18.85MC$ -16.84MC$ -14.56MC$ -12.59M
Operating Income
C$ -14.80MC$ -18.76MC$ -17.52MC$ -15.87MC$ -14.03M
Other Income/Expenses
C$ 393.00KC$ -609.00KC$ -32.56MC$ -336.00KC$ 38.00K
Pretax Income
C$ -14.41MC$ -19.37MC$ -50.09MC$ -16.21MC$ -13.99M
Net Income
C$ -14.41MC$ -20.78MC$ -82.82MC$ -16.92MC$ -14.16M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.07C$ -0.11C$ -1.04C$ -0.09C$ -0.07
Diluted EPS
C$ -0.07C$ -0.11C$ -1.04C$ -0.09C$ -0.07
Weighted Average Shares Outstanding
197.11M 194.59M 79.64M 194.58M 194.58M
Weighted Average Shares Outstanding (Diluted)
197.11M 194.59M 79.64M 194.58M 194.58M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis